Pfizer to gains ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B deal
November 09 2021 - 8:13AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Biohaven (NYSE:BHVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biohaven (NYSE:BHVN)
Historical Stock Chart
From Apr 2023 to Apr 2024